In 2 waves during the 1990s and early 2000s, hospitals and large health systems acquired numerous specialty and primary care medical practices across the United States. Many specialties experienced substantial shifts toward employed physicians,1 but as recently as 2014, the majority of dermatologists remained in solo practices (35%) or single-specialty groups (41%).2 While a few dermatology practice groups did pursue strategic consolidations, it seemed that the specialty had deferred some of the controversies inherent in practice acquisition by nonphysicians. In the last 3 to 5 years, however, consolidation of practices fueled by private equity (PE) investments has begun to transform dermatology.